Skip to main content

Sigma Pharmaceuticals plc – Winners of the Business Excellence SME of the Year 2018

29th October 2018 General

Sigma Pharmaceuticals plc were the proud recipients of the Business Excellence SME of the Year 2018 Award presented at the London Marriott Hotel Regents Park.

The award was made to Dr Bharat Shah, Sigma’s Chairman who collected it on behalf of the company.

JITOPRENEURS is an annual global initiative of JITO (Jain International Trade Organisation) G2G dedicated to promoting entrepreneurship, global networking and learning to its members. 

Following the success of three international conferences at Dubai, San Francisco and London, JITO G2G staged its fourth International Business and Networking Conference: JITOPRENEURS 2018 in London again.

Through the conference and subsequent awards ceremony, JITOPRENEURS aims to create a unique global umbrella of successful entrepreneurs from various business sectors, drawn from various parts of the world.

Amongst many other compelling factors, Sigma won the Business Excellence SME Award this year due to its new site being the first of its kind in Britain to merge FMD (Falsified Medicines Directive) standards into one, ‘start-to-finish’ operation.  The Directive will come into force in February 2019 and Sigma has already implemented the standard as part of its normal operations from the launch of its new site in 2018.

The Directive will track every drug and medicine right through the supply chain from manufacturer, through to wholesaler, to pharmacist and eventually down to the hands of the patient.  In this way, every prescription can be tracked to source, instantly.

In a recent inspection by the Regulator, the MHRA, to sign off Sigma’s new premises as fit for purpose, they were “highly commended” for including this Directive into Sigma’s mainstream operation.

Managing Director Bharat Shah said: “We were delighted to be the recipients of this prestigious award from JITO that recognises business excellence and innovation.  As a wholesaler to the independent sector, we take service delivery and compliance issues very seriously, hence the substantial investment into FMD integration in our new plant.  This new way of delivering medicines and drugs is designed to make life easier for pharmacists and to make tracking and accountability a daily routine.  ”